| Literature DB >> 29213262 |
Nikola Strempel1, Michael Nusser1, Anke Neidig1, Gerald Brenner-Weiss1, Joerg Overhage1,2.
Abstract
The opportunistic human pathogen Pseudomonas aeruginosa is able to survive under a variety of often harmful environmental conditions due to a multitude of intrinsic and adaptive resistance mechanisms, including biofilm formation as one important survival strategy. Here, we investigated the adaptation of P. aeruginosa PAO1 to hypochlorite (HClO), a phagocyte-derived host defense compound and frequently used disinfectant. In static biofilm assays, we observed a significant enhancement in initial cell attachment in the presence of sublethal HClO concentrations. Subsequent LC-MS analyses revealed a strong increase in cyclic-di-GMP (c-di-GMP) levels suggesting a key role of this second messenger in HClO-induced biofilm development. Using DNA microarrays, we identified a 26-fold upregulation of ORF PA3177 coding for a putative diguanylate cyclase (DGC), which catalyzes the synthesis of the second messenger c-di-GMP - an important regulator of bacterial motility, sessility and persistence. This DGC PA3177 was further characterized in more detail demonstrating its impact on P. aeruginosa motility and biofilm formation. In addition, cell culture assays attested a role for PA3177 in the response of P. aeruginosa to human phagocytes. Using a subset of different mutants, we were able to show that both Pel and Psl exopolysaccharides are effectors in the PA3177-dependent c-di-GMP network.Entities:
Keywords: Pseudomonas aeruginosa; bacterial stress response; biofilm formation; c-di-GMP; oxidative stress; pathogen
Year: 2017 PMID: 29213262 PMCID: PMC5702645 DOI: 10.3389/fmicb.2017.02311
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Plasmids and bacterial strains used in this study.
| Description | Reference | |
|---|---|---|
| pJN105 | Broad-host-range expression vector derived from pBBR1MCS-5, contains araC-pBAD, | |
| pJN3177 | Overexpression of | This study |
| pJN2133 | Overexpression of | |
| pET23a | Novagen, Merck Millipore | |
| pET3177 | Vector for heterologous overexpression of PA3177 in | This study |
| PAO1 | Wildtype strain | |
| PAO1-PA3177Ω | PAO1 transposon insertion mutant, ID: PAO1_lux_66:D11, PA3177 knock-out, TcR | |
| PAO1-Δ | PAO1 deletion mutant, | |
| PAO1-Δ | PAO1 deletion mutant, | |
| PAO1-Δ | PAO1 deletion double mutant, | |
| PAO1- | PAO1 transposon insertion mutant, ID:PAO1_lux_24:H1, | |
| PAO1-pJN105 | Vector control strain | This study |
| PAO1-pJN3177 | Overexpression of PA3177 in strain PAO1 | This study |
| PAO1-pJN2133 | Overexpression of PA2133 in strain PAO1 | This study |
| PAO1-pJN3177- | Overexpression of a PA3177-GFP fusion protein in strain PAO1 | This study |
| PAO1-Δ | Overexpression of PA3177 in strain PAO1-Δ | This study |
| PAO1-Δ | Overexpression of PA3177 in strain PAO1-Δ | This study |
| PAO1-Δ | Overexpression of PA3177 in strain PAO1-Δ | This study |
| PAO1- | Overexpression of PA3177 in strain PAO1- | This study |
| DH5α | Cloning strain | Invitrogen |
| BL21 (DE3) | Expression strain | Stratagene |
| BL21-pET23a | Vector control strain | This study |
| BL21-pET3177 | Heterologous expression of PA3177 in strain BL21(DE3) | This study |
PA3177 gene expression in response to different oxidantsa.
| Compound | Applied concentration | Relative gene expressionc |
|---|---|---|
| NaClO | 2 μg/ml free chlorineb | 13.7 ± 0.9 |
| Ca(ClO)2 | 2 μg/ml free chlorine | 86.0 ± 4.0 |
| NH2Cl | 28.6 ± 4.9 | |
| H2O2 | 50 μg/ml (1.47 mM) | 1.2 ± 0.1 |
| Paraquat | 1 μg/ml (3.88 mM) | 2.2 ± 0.2 |